The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index; 19 of the 61 sources its claims cite were checked for support.
3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels
Open accessPublished version of a preprint
Abstract
Cellular models are needed to study human development and disease in vitro, and to screen drugs for toxicity and efficacy. Current approaches are limited in the engineering of functional tissue models with requisite cell densities and heterogeneity to appropriately model cell and tissue behaviors. Here, we develop a bioprinting approach to transfer spheroids into self-healing support hydrogels at high resolution, which enables their patterning and fusion into high-cell density microtissues of prescribed spatial organization. As an example application, we bioprint induced pluripotent stem cell-derived cardiac microtissue models with spatially controlled cardiomyocyte and fibroblast cell ratios to replicate the structural and functional features of scarred cardiac tissue that arise following myocardial infarction, including reduced contractility and irregular electrical activity. The bioprinted in vitro model is combined with functional readouts to probe how various pro-regenerative microRNA treatment regimes influence tissue regeneration and recovery of function as a result of cardiomyocyte proliferation. This method is useful for a range of biomedical applications, including the development of precision models to mimic diseases and the screening of drugs, particularly where high cell densities and heterogeneity are important.
Overview
CoChat Summary
TL;DR
The paper presents a 3D bioprinting method that transfers spheroids into self-healing hyaluronic acid hydrogels, enabling precise patterning and fusion into high-cell-density microtissues. It applies the method to create iPSC-derived cardiac microtissues with controlled cardiomyocyte:fibroblast ratios that model post-MI scarring and to test miR-302b/c therapeutics.
Key findings
- Bioprinting into 3 wt% guest-host HA hydrogels achieved XY drift of ~8–15% (~15–60 µm) and Z drift of ~10–15% (~25–60 µm) of spheroid diameter; viability was ~90–95% at 3 and 5 wt% but ~87% at 7 wt%, with a per-spheroid print time of ~40 s at 400 µm/s.
- Spheroids bioprinted in direct contact or 50 µm apart fused over 4 days; fusion index at day 0 differed between 0 and 50 µm separation (p = 0.0025), and introducing a secondary covalent network significantly reduced fusion.
- Cardiac spheroids made at 4:1 iPSC-CMs:CFs (“healthy”) versus 1:4 (“scarred”) showed higher healthy contraction amplitude (p = 5.0 × 10−4), higher calcium transient duration (p = 0.0014) and calcium flux amplitude (p = 2.0 × 10−4), and lower time-to-peak (p = 5.0 × 10−6); scarred microtissues had increased activation delay (p = 0.0035), and two scars increased delay versus one scar (p = 0.0066).
- miR-302b/c treatment for 4 or 7 days increased scarred spheroid contraction amplitude approximately threefold, approaching ~20% of healthy spheroid amplitudes, and increased contraction speed ~2×; it increased cTnT+EdU+ proliferation (0 vs 0–4 days p = 0.044; 0 vs 0–7 days p = 0.026) without increasing Vimentin+EdU+ cells, and reduced activation delay in scarred microtissues (p = 0.019).
Methods
- Ad-HA/CD-HA supramolecular hydrogels were prepared at 3, 5, and 7 wt%, characterized by shear rheometry for shear-thinning and self-healing, and used as support baths for vacuum-aspiration bioprinting of spheroids via a micromanipulator and custom micropipettes.
- hMSC spheroids (5,000 or 10,000 cells; ~200 or ~400 µm diameter) and cardiac spheroids (5,000 total iPSC-CMs plus human cardiac fibroblasts at 4:1 healthy or 1:4 scarred ratios) were formed in ultra-low attachment plates; outcomes included fusion, live/dead viability, contraction analysis with musclemotion, calcium mapping with ElectroMap, immunofluorescence, EdU proliferation, and miRNA treatment.
- Statistical comparisons used two-tailed Student’s t tests or one-way ANOVA with Tukey post hoc testing; exact p values are reported in figure legends, with sample distribution assumed normal and equal variance.
Limitations
- The paper states that spheroid-based microtissues lack the anisotropic tissue alignment of mature myocardium and do not include vascular networks, and that iPSC-CMs are immature, mimicking fetal rather than adult cardiomyocytes.
- The paper notes that live cell area was used as an approximate heuristic for viability because per-cell viability was difficult to quantify in dense spheroids.
- Evident from the text: many experiments used a single MSC donor and a single iPSC-CM donor (donor A or donor B), limiting donor diversity; some reported comparisons are trends or non-significant, such as scarred microtissue contraction amplitude (p = 0.061).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
9 Valid · 2 Not valid · 21 Not checked · 93 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In these formats they are promising as drug screening platforms due to their superior predictability and physiological structure and function when compared to traditional monolayer cultures7–10.”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Introduction
What the sources say
- Not checked yetcites [7] Mills, R. J. et al. Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway. Cell Stem Cell 24, 895–907.e896 (2019). source
- Not checked yetcites [8] Ranga, A., Gjorevski, N. & Lutolf, M. P. Drug discovery through stem cell-based organoid models. Adv. drug Deliv. Rev. 69-70, 19–28 (2014). source
- Not checked yetcites [9] Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671–687 (2018). source
- Partly supportedcites [10] Fatehullah, A., Tan, S. H. & Barker, N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18, 246–254 (2016). sourceExperimental — accuracy not yet measured
The introduction says organoids are more physiologically relevant than traditional 2D monolayer cultures, and Applications of organoid technology describes their use in drug screening while noting limitations of 2D cell lines as accurate models. But the paper makes those comparisons about organoids, not spheroids generally: its Figure 1 caption describes spheroids as an intermediate that is embedded in ECM to initiate organoid culture. It does not establish superior predictive performance for spheroids. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in a more recent porcine MI model, prolonged expression of Hippo inhibiting miRNA-199a through viral transfection resulted in sudden cardiac failure in 70% of the treated pigs59.”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Results and discussion > Evaluating the behavior of cardiac microtissues in response to miRNA therapeutics
What the sources say
- Supportedcites [59] Gabisonia, K. et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569, 418–422 (2019). source
The Abstract (page not available) reports persistent expression of virally delivered miR-199a and downregulation of Hippo-pathway factors in pigs after MI. It reports sudden death in 7 of 10 treated pigs at weeks 7–8; ECG recordings in two showed ventricular fibrillation. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recent pre-clinical evidence indicates that Hippo pathway inhibiting miRNAs can stimulate CM proliferation34,57,58.”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Results and discussion > Evaluating the behavior of cardiac microtissues in response to miRNA therapeutics
What the sources say
- Supportedcites [34] Wang, L. L. et al. Sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischaemic injury. Nat. Biomed. Eng. 1, 983–992 (2017). source
The cholesterol-modified mimics section reports that miR-302b and miR-302c increased cardiomyocyte proliferation and knocked down Hippo signaling targets. The in vivo bioactivity section reports cardiomyocyte proliferation after gel/miR-302 injection and increased nuclear Yap, consistent with Hippo pathway inhibition in this preclinical mouse study. (LLM, conf=0.94)
- Supportedcites [57] Tian, Y. et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci. Transl. Med. 7, 279ra238 (2015). source
The Results section ('miR302–367 inhibits the Hippo pathway to promote cardiomyocyte proliferation') reports that miR302–367 represses Hippo-pathway components and that its overexpression increased proliferation in neonatal mouse cardiomyocytes. The Discussion also reports increased cardiomyocyte proliferation after transient treatment of mice with miR302 mimics, matching the claim's preclinical scope. (LLM, conf=0.94)
- Supportedcites [58] Diez-Cuñado, M. et al. miRNAs that Induce Human Cardiomyocyte Proliferation Converge on the Hippo Pathway. Cell Rep. 23, 2168–2174 (2018). source
The Introduction reports that a screen identified miRNAs that stimulate DNA synthesis and cell division in human induced pluripotent stem cell-derived cardiomyocytes. It also states that computational and functional studies showed most of these pro-proliferative miRNAs act by targeting the Hippo/YAP pathway, supporting the pre-clinical claim. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“CFs themselves cannot generate action potentials”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Results and discussion > 3D bioprinting cardiac microtissues for disease modelling applications
What the sources say
- Could not verifycites [53] Travers Joshua, G., Kamal Fadia, A., Robbins, J., Yutzey Katherine, E. & Blaxall Burns, C. Cardiac Fibrosis. Circulation Res. 118, 1021–1040 (2016). sourceExperimental — accuracy not yet measured
The Electrical Communication section (page unavailable) says cardiac fibroblasts conduct electrical signals and can couple electrically with cardiomyocytes. It does not say whether fibroblasts can generate action potentials themselves. Searches for “action potential” and “electrically non-excitable fibroblasts” found no passage settling that distinction. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The contraction amplitude (absolute unit, a.u) is an optical measure of contraction and is widely used for cardiac spheroid studies and correlates with the force of contraction, which has been validated across single adult CMs, iPSC-CMs, cardiac spheroids, and engineered heart tissues55.”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Methods > 3D bioprinting cardiac microtissues and contraction imaging
What the sources say
- Partly supportedcites [55] Sala, L. et al. MUSCLEMOTION: a Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo. Circulation Res. 122, e5–e16 (2018). sourceExperimental — accuracy not yet measured
Our copy supports the optical-measure part and cross-configuration validation: the Results section 'Algorithm Application to Multiple Cell Configurations and Correlation With Existing Gold Standards' reports MUSCLEMOTION outputs correlating with standard methods in single hPSC-CMs, monolayers, cardiac organoids, EHTs and adult rabbit cardiomyocytes, and specifically that 'contraction amplitudes in EHTs showed high linear correlation (R2=0.879) with the absolute force values derived from measurement of pole deflection'. However, the correlation with FORCE is shown only for EHTs (plus bead-displacement in single CMs, Figure 3B); for adult CMs the correlate was sarcomere fractional shortening (R2=0.871) and for single hPSC-CMs/organoids it was optical flow velocity, so the claim that force-correlation was validated across all four configurations overstates the source. The Discussion > Limitations also states 'MUSCLEMOTION does not measure absolute values of cell shortening or force of contraction' (calibratable via correlations), and nothing in our copy asserts the metric is 'widely used for cardiac spheroid studies' or glosses a.u. as 'absolute unit'. (LLM, conf=0.78)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
47 more claims
Create a free account to see all 125 claims and to verify the 42 references still open.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 53
- The quote only partly states this claim. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Particularly, 3D printing has been increasingly used for engineering tissue models for enabling facile design and editing of 3D structure prior to printing, and fabrication of complex 3D structures with flexible formulation of biomaterial inks21–23.”
From Fibre-infused gel scaffolds guide cardiomyocyte alignment in 3D-printed ventricles (2023) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Introduction
“The self-healing properties of the support hydrogel enable precise positioning of spheroids (up to 10% of spheroid diameter)”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Results and discussion > 3D bioprinting spheroids within self-healing hydrogels
“For XY precision, we measured drift distances of ~8–15% of the spheroid diameter (or ~15–60 µm) for all polymer concentrations (Fig. 2b i, Supplementary Fig. 4b i). For Z precision, we measured similar drift distances of ~10–15% of the spheroid diameter”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Results and discussion > 3D bioprinting cardiac microtissues for disease modelling applications
“e Regional quantification of (i) calcium transient duration (ms), (ii) time-to-peak (ms), and (iii) calcium flux amplitude (F/Fo), in healthy and scarred regions of microtissues (scarred 1x) after 5 days of culture”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Methods > 3D bioprinting cardiac microtissues and contraction imaging
“ten total spheroids were bioprinted in a ring that contained two scarred spheroids at opposite ends of the ring (Fig. 5d, e).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Results and discussion > 3D bioprinting spheroids within self-healing hydrogels
“decreased viscosity with continuously increasing shear rates (0–100 s−1)”
§ 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels > Methods > Rheological characterization
“To assess shear-thinning properties, viscosity was measured as a function of shear rate (0–50 s−1).”
Citations
Cites
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
25th Anniversary Article: Engineering Hydrogels for Biofabrication
Malda, J., Visser, J., Melchels, F. P., Jüngst, T., Hennink, W. E., Dhert, W. J. A., Groll, J., & Hutmacher, D. W. (2013) · Advanced Materials · doi:10.1002/adma.201302042 · Cited by 1,901
Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790
Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis
Takasato, M., Er, P. X., Chiu, H. S., Maier, B., Baillie, G. J., Ferguson, C., Parton, R. G., Wolvetang, E. J., Roost, M. S., Chuva de Sousa Lopes, S. M., et al. (2015) · Nature · doi:10.1038/nature15695 · Cited by 1,627
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508
Assembly of functionally integrated human forebrain spheroids
Birey, F., Andersen, J., Makinson, C. D., Islam, S., Wei, W., Huber, N., Fan, H. C., Metzler, K. R. C., Panagiotakos, G., Thom, N., et al. (2017) · Nature · doi:10.1038/nature22330 · Cited by 1,365
Scaffold-free vascular tissue engineering using bioprinting
Norotte, C., Marga, F. S., Niklason, L. E., & Forgacs, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.034 · Cited by 1,339
Advanced maturation of human cardiac tissue grown from pluripotent stem cells
Ronaldson-Bouchard, K., Ma, S. P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., & Vunjak-Novakovic, G. (2018) · Nature · doi:10.1038/s41586-018-0016-3 · Cited by 1,272
Cited by
Cao, H., Duan, L., Zhang, Y., Cao, J., & Zhang, K. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00830-x · Cited by 1,274
Hofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184
Self-Healing Injectable Hydrogels for Tissue Regeneration
Bertsch, P., Diba, M., Mooney, D. J., & Leeuwenburgh, S. C. G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00179 · Cited by 892
“653 Daly et al. 654 have exploited this approach to create heterogeneous tissue constructs, as shown in Figure 10D.”
Zhang, Y. S., Haghiashtiani, G., Hübscher, T., Kelly, D. J., Lee, J. M., Lutolf, M., McAlpine, M. C., Yeong, W. Y., Zenobi-Wong, M., & Malda, J. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00073-8 · Cited by 391
The rheology of direct and suspended extrusion bioprinting
Cooke, M. E., & Rosenzweig, D. H. (2021) · APL Bioengineering · doi:10.1063/5.0031475 · Cited by 284
Metadata
- Authors
- Daly, A. C., Davidson, M. D., & Burdick, J. A.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Burdick, Jason A.
- Venue
- Nature Communications
- Published
- 2021-02-02
- Volume
- 12
- Issue
- 1
- Pages
- 753-753
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC7854667
- OpenAlex
- W3126743042
- Semantic Scholar
- 27b7f9fb93947cff9d3bcadc142b1cbaa6b9636a
- Cited by
- 470
- References
- 76
- Citations by year
- 2026: 53 · 2025: 87 · 2024: 94 · 2023: 92 · 2022: 83 · 2021: 60
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Heart Association (20POST35210923)
- U.S. Department of Health & Human Services | National Institutes of Health (F32 DK117568, R01HL137365, R01HL135090)
- National Science Foundation (CMMI: 15-48571)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- 3D bioprinting, spheroid fusion, self-healing hydrogels, high cell density, iPSC-derived cardiomyocytes, cardiac microtissues, myocardial infarction, microRNA, cardiomyocyte proliferation, tissue regeneration, drug screening, disease modeling
- MeSH terms
- Biomedical Engineering, Cardiovascular Diseases, Drug Evaluation, Preclinical, Drug Delivery Systems, Spheroids, Cellular, Hydrogels, Tissue Engineering, Pluripotent Stem Cells, Bioprinting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels. https://app.cochat.ai/papers/10.1038/s41467-021-21029-2
- The paper
- Daly, A. C., Davidson, M. D., & Burdick, J. A. (2021). 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels. Nature Communications. https://doi.org/10.1038/s41467-021-21029-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.